Drug recall · June 16, 2021
Levetiracetam Tablets USP recall
Why: Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India NDC 63739-795-10
- Lots / codes
Lot: 0000124916 Exp. 09/30/2022
- Quantity
- 210 cartons
- Company
- McKesson Corporation dba McKesson Drug Company, Memphis, TN
- Distribution
- Nationwide in the US
- Initiated
- May 26, 2021 · Voluntary: Firm initiated
- Classified
- June 15, 2021
- Reported
- June 16, 2021
- Ended
- September 29, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levetiracetam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.